Recalls & Warnings September 24, 2020 FTC Sends Refund Checks to Consumers of Deceptive Joint Pain Supplement On September 24, 2020, the FTC announced it is mailing 4,782 checks totaling more than $76,000 to consumers who bought Isoprex, a supplement marketed with deceptive claims that it could treat or cure joint pain, muscle pain, headaches, and arthritis
Mounjaro vs Zepbound: Key Differences and Considerations For individuals assessing treatment options, understanding the differences between mounjaro vs zepbound is vital, particularly when considering coverage implications
Researchers should monitor FDA inspection results, enforcement actions, and company communications over time to assess whether BPI Labs is on an upward quality trajectory
Patients on PlexusDx's microdose GLP-1 protocol may experience gentler energy shifts since this approach uses lower initial doses to minimize side effects
1 2 3 4 5 6 7 8 "Exenatide Monograph for Professionals"